查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566943

脊椎骨水泥市场：按类型、应用和最终用户分类：2024-2033 年全球机会分析和产业预测

Bone Cement for Spine Market By Type (Low Viscosity, Medium Viscosity, High Viscosity) , By Application (Vertebroplasty, Kyphoplasty) By End User (Hospitals, Specialty Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

脊椎骨水泥市场

2023年脊椎骨水泥市场价值为1.012亿美元，预计2024年至2033年复合年增长率为5.3%，2033年达到1.686亿美元。

用作脊椎骨水泥的化学物质是聚甲基丙烯酸甲酯。这种水泥特别用于脊椎手术，例如骨成形术和椎体成形术。这种水泥用于支撑脆弱、骨折的骨骼，提供力量并缓解疼痛。骨水泥的主要特性是它能够快速硬化，为脊椎提供直接的结构支撑和稳定性。

全球脊椎手术数量的增加是脊椎骨水泥市场的主要驱动因素。此外，骨脆性高的老年人口的迅速增加正在推动脊椎骨水泥的需求。最近，有一种趋势是利用积层製造在支架和骨植入的设计中使用骨水泥。这使我们能够根据患者的具体要求製造客製化的脊椎移植。此外，使用骨水泥作为局部药物输送的载体已获得医疗保健产业的大力支持。

然而，脊柱骨水泥在体内容易发生碎裂和异物反应，导致假体关节鬆动、假体周围骨溶解等危险状况。这些反应正在阻碍市场的开拓。相反，脊椎手术数量的不断激增预计将为市场开拓提供利润丰厚的机会。根据世界卫生组织（WHO）统计，2021年全球约有1,540万人将因交通事故、跌倒、暴力等多种原因遭受脊髓损伤。此外，根据全球资料和商业情报平台 Statista 的数据，到 2023年终，美国将有约 305,000 人遭受脊髓损伤。这些引人注目的数字表明脊柱骨水泥市场的未来充满希望。

按部门审查

脊椎骨水泥市场按类型、应用、最终用户和地区细分。依类型可分为低黏度、中黏度、高黏度。依应用范围可分为椎体成形术和椎体成形术。依最终用户划分，可分为医院和专科手术中心。从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区进行了分析。

主要发现

从类型来看，中黏度细分市场将在 2023 年占据较高的市场份额。

从应用来看，枕叶成形术领域在 2023 年获得了较高的市场份额。

按最终用户划分，医院细分市场在 2023 年将占据较高市场份额。

按地区划分，北美地区 2023 年收益最高。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章脊椎骨水泥市场：依类型

  • 市场概况
  • 低黏度
  • 中等黏度
  • 高黏度

第五章脊椎骨水泥市场：依应用分类

  • 市场概况
  • 椎体成形术
  • 椎体成形术

第六章脊椎骨水泥市场：依最终用户分类

  • 市场概况
  • 医院
  • 专科手术中心

第七章脊椎骨水泥市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国脊椎骨水泥市场
    • 加拿大脊椎骨水泥市场
    • 墨西哥脊椎骨水泥市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国脊椎骨水泥市场
    • 法国脊椎骨水泥市场
    • 英国脊椎骨水泥市场
    • 义大利脊椎骨水泥市场
    • 西班牙脊椎骨水泥市场
    • 其他欧洲国家脊椎骨水泥市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本脊椎骨水泥市场
    • 中国脊椎骨水泥市场
    • 澳洲脊椎骨水泥市场
    • 印度脊椎骨水泥市场
    • 韩国脊椎骨水泥市场
    • 其他亚太地区脊椎骨水泥市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西脊椎骨水泥市场
    • 沙乌地阿拉伯脊椎骨水泥市场
    • 南非脊椎骨水泥市场
    • 其他拉丁美洲/中东/非洲脊椎骨水泥市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Cardinal Health
  • Meta Biomed Co., Ltd
  • Heraeus Medical GmbH
  • Shanghai Rebone, Tecres SPA
  • OSARTIS GmbH
  • Stryker Corporation
  • Johnson And Johnson
  • Heraeus Medical
  • Smith And Nephew Plc
  • Medtronic
简介目录
Product Code: A323979

Bone Cement for Spine Market

The bone cement for spine market was valued at $101.2 million in 2023 and is projected to reach $168.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

The chemical used as a bone cement for spine is polymethyl methacrylate. The cement is specifically used for spinal surgeries such as kyphoplasty and vertebroplasty. This cement is administered to provide support to weakened broken bones, provide them with strength, and aid in relieving pain. A major attribute of the bone cement is its ability to solidify quickly, providing instant structural support and stability to the spine.

Increase in the prevalence of spinal surgeries across the globe is a key driver of the bone cement for spine market. In addition, the exponentially growing elderly population with high bone fragility is boosting the demand for bone cement for spine. In recent times, the trend of using bone cement as a material for the designing of scaffolds and bone implants through additive manufacturing is acquiring noteworthy traction. This enables the creation of tailored spine implants, according to the specific requirement of patients. Furthermore, the use of bone cement as a carrier for localized drug delivery is gaining significant traction in the healthcare industry.

However, bone cement for spine remains highly susceptible to fragmentation & foreign substance reaction inside the body, which leads to threatening conditions such as prosthetic loosening and periprosthetic osteolysis. These reactions hamper the development of the market. On the contrary, a constant surge in the number of spinal surgeries is projected to present lucrative opportunities for the market development. According to the statistics of the World Health Organization, approximately 15.4 million individuals were suffering from spinal cord injuries in 2021 globally owing to several reasons such as road accidents, falls, or violence. Moreover, Statista-a global data and business intelligence platform-states that around 305,000 individuals in the U.S. had a spinal cord injury by the end of 2023. These eminent figures indicate a promising future for the bone cement for spine market.

Segment Review

The bone cement for spine market is segmented into type, application, end user, and region. On the basis of type, the market is divided into low viscosity, medium viscosity, and high viscosity. As per application, it is bifurcated into vertebroplasty and kyphoplasty. Depending on end user, it is classified into hospitals and specialty surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the medium viscosity segment held a high share of the market in 2023.

As per application, the kyphoplasty segment acquired a high stake in the market in 2023.

Depending on end user, the hospitals segment was the highest shareholder of the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The key players operating in the global bone cement for spine market include Cardinal Health, Meta Biomed Co., Ltd, Heraeus Medical GmbH, Shanghai Rebone, Tecres S.P.A, OSARTIS GmbH, Stryker Corporation, Johnson & Johnson, Heraeus Medical, Smith & Nephew plc, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Low Viscosity
  • Medium Viscosity
  • High Viscosity

By Application

  • Vertebroplasty
  • Kyphoplasty

By End User

  • Hospitals
  • Specialty Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cardinal Health
    • Meta Biomed Co., Ltd
    • Heraeus Medical GmbH
    • Shanghai Rebone, Tecres S.P.A
    • OSARTIS GmbH
    • Stryker Corporation
    • Johnson & Johnson
    • Heraeus Medical
    • Smith & Nephew plc
    • Medtronic

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BONE CEMENT FOR SPINE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Low Viscosity
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Medium Viscosity
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. High Viscosity
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BONE CEMENT FOR SPINE MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Vertebroplasty
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Kyphoplasty
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: BONE CEMENT FOR SPINE MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: BONE CEMENT FOR SPINE MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Bone Cement for Spine Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Bone Cement for Spine Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Bone Cement for Spine Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Bone Cement for Spine Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Bone Cement for Spine Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Bone Cement for Spine Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Bone Cement for Spine Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Bone Cement for Spine Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Bone Cement for Spine Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Bone Cement for Spine Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Bone Cement for Spine Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Bone Cement for Spine Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Bone Cement for Spine Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Bone Cement for Spine Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Bone Cement for Spine Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Bone Cement for Spine Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Bone Cement for Spine Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Bone Cement for Spine Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Bone Cement for Spine Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Cardinal Health
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Meta Biomed Co., Ltd
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Heraeus Medical GmbH
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Shanghai Rebone, Tecres S.P.A
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. OSARTIS GmbH
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Stryker Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Johnson And Johnson
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Heraeus Medical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Smith And Nephew Plc
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Medtronic
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments